title: Chemokine-based immunotherapy: delivery systems and combination therapies.
abstract: A major role of chemokines is to mediate leukocyte migration through interaction with G-protein-coupled receptors. Various delivery systems have been developed to utilize the chemokine properties for combating disease. Viral and mutant viral vectors expressing chemokines, genetically modified dendritic cells with chemokine or chemokine receptors, engineered chemokine-expressing tumor cells and pDNA encoding chemokines are among these methods. Another approach for inducing a targeted immune response is fusion of a targeting antibody or antibody fragment to a chemokine. In addition, chemokines induce more effective antitumor immunity when used as adjuvants. In this regard, chemokines are codelivered along with antigens or fused as a targeting unit with antigenic moieties. In this review, several chemokines with their role in inducing immune response against different diseases are discussed, with a major emphasis on cancer.
authors.affiliation: Molecular Immunology & Vaccine Research Lab, Pasteur Institute of Iran, Tehran 13164, Iran.
authors.forename: Elham
authors.initials: E
authors.lastname: Mohit
authors.forename: Sima
authors.initials: S
authors.lastname: Rafati
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D018925:Chemokines / Q000235:genetics / Q000276:immunology*; D003131:Combined Modality Therapy; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000628:therapy*; D019707:Receptors, Chemokine / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology
chemical_list: D000951:Antigens, Neoplasm; D018925:Chemokines; D019707:Receptors, Chemokine; D011993:Recombinant Fusion Proteins